Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pegylated interferon therapy-related microRNA-6126 downregulates sodium taurocholate cotransporting polypeptide expression in hepatocytes. | Gene | 2023 | 36427676 | PubTator, text mining | PubMed |
| Indocyanine green (ICG) fluorescence in robotic hepatobiliary surgery: A systematic review. | Int J Med Robot | 2023 | 36417426 | PubTator, text mining | PubMed |
| Levothyroxine: Conventional and Novel Drug Delivery Formulations. | Endocr Rev | 2023 | 36412275 | PubTator, text mining | PubMed |
| Novel nitroxide-bile acid conjugates inform substrate requirements for human bile acid transporters. | Eur J Pharm Sci | 2023 | 36402308 | PubTator, text mining | PubMed |
| Physiomimetic In Vitro Human Models for Viral Infection in the Liver. | Semin Liver Dis | 2023 | 36402129 | PubTator, text mining | PubMed |
| A functional variant of CD40 modulates clearance of hepatitis B virus in hepatocytes via regulation of the ANXA2/CD40/BST2 axis. | Hum Mol Genet | 2023 | 36383401 | PubTator, text mining | PubMed |
| Release of hepatitis B virions is positively regulated by glucose-regulated protein 78 through direct interaction with preS1. | J Med Virol | 2023 | 36321566 | PubTator, text mining | PubMed |
| Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance. | Gut | 2023 | 36316098 | PubTator, text mining | PubMed |
| Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia. | Nat Rev Endocrinol | 2023 | 36289368 | PubTator, text mining | PubMed |
| Hepatitis B Virus Utilizes a Retrograde Trafficking Route via the Trans-Golgi Network to Avoid Lysosomal Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36270602 | PubTator, text mining | PubMed |
| Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure. | Gastroenterology | 2023 | 36243037 | PubTator, text mining | PubMed |
| 3D engineered tissue models for studying human-specific infectious viral diseases. | Bioact Mater | 2023 | 36204281 | PubTator, text mining | PubMed |
| Presence of Intact Hepatitis B Virions in Exosomes. | Cell Mol Gastroenterol Hepatol | 2023 | 36184032 | PubTator, text mining | PubMed |
| Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy. | Hepatology | 2023 | 36131538 | PubTator, text mining | PubMed |
| A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics. | Br J Clin Pharmacol | 2023 | 35942816 | PubTator, text mining | PubMed |
| Bulevirtide for patients with compensated chronic hepatitis delta: A review. | Liver Int | 2023 | 35942695 | PubTator, text mining | PubMed |
| Baohuoside I inhibits FXR signaling pathway to interfere with bile acid homeostasis via targeting ER α degradation. | Cell Biol Toxicol | 2023 | 35802278 | PubTator, text mining | PubMed |
| Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells. | Hepatology | 2023 | 35718932 | PubTator, text mining | PubMed |
| Regulation of body weight: Lessons learned from bariatric surgery. | Mol Metab | 2023 | 35644477 | PubTator, text mining | PubMed |
| Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH). | Clin Pharmacol Ther | 2023 | 35429164 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=29